Acumen Pharmaceuticals
ABOS
ABOS
70 hedge funds and large institutions have $43.6M invested in Acumen Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-10
Holders Change %
-12.5%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
15
Reduced
22
Closed
27
Calls
$46K
Puts
$2K
Net Calls
+$44K
Net Calls Change
+$66K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$2.26M |
| 2 |
ACM
2
ADAR1 Capital Management
Austin,
Texas
|
$1.06M |
| 3 |
YIH
3
Y-Intercept (HK)
Hong Kong
|
$291K |
| 4 |
4
Jane Street
New York
|
$204K |
| 5 |
5
Goldman Sachs
New York
|
$388K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$339K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$29.2K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$460K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$124K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.96M |
